Clinical Trial Update: Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

View source ↗

Summary

A clinical trial evaluating SLV320 added to chronic furosemide treatment in subjects with congestive heart failure and impaired renal function was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FUROSEMIDE (Furosemide)
• SLV320

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Congestive Heart Failure | Status: TERMINATED